|
Volumn 584, Issue 1, 2007, Pages 153-159
|
Development and validation of a reversed-phase ion-pair high-performance liquid chromatographic method for the determination of risedronate in pharmaceutical preparations
|
Author keywords
Ion pair liquid chromatography; Magnesium ascorbyl phosphate; Pharmaceutical dosage forms; Risedronate; Stability indicating
|
Indexed keywords
ION-PAIR LIQUID CHROMATOGRAPHY;
MAGNESIUM ASCORBYL PHOSPHATE;
PHARMACEUTICAL DOSAGE FORMS;
RISEDRONATE;
STABILITY INDICATING;
ACETONITRILE;
DRUG DOSAGE;
DRUG PRODUCTS;
PHASE SEPARATION;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
ACETONITRILE;
ASCORBIC ACID DERIVATIVE;
HYDROXIDE;
MAGNESIUM ASCORBYL PHOSPHATE;
MAGNESIUM DERIVATIVE;
PHOSPHATE;
PYROPHOSPHATE;
RISEDRONIC ACID;
TETRABUTYLAMMONIUM;
TETRABUTYLAMMONIUM HYDROXIDE;
UNCLASSIFIED DRUG;
ANALYTICAL ERROR;
ARTICLE;
CALIBRATION;
DRUG DETERMINATION;
DRUG DOSAGE FORM;
ION PAIR CHROMATOGRAPHY;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
STANDARD;
VALIDATION STUDY;
CALCIUM CHANNEL BLOCKERS;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
ETIDRONIC ACID;
HYDROGEN-ION CONCENTRATION;
PHARMACEUTICAL PREPARATIONS;
REPRODUCIBILITY OF RESULTS;
SPECTROPHOTOMETRY, ULTRAVIOLET;
TABLETS;
|
EID: 33846301626
PISSN: 00032670
EISSN: None
Source Type: Journal
DOI: 10.1016/j.aca.2006.11.012 Document Type: Article |
Times cited : (24)
|
References (16)
|